Pharmacokinetics and Safety of Oral Doses of Meloxicam in Foals Less Than Six Weeks of Age

Sharanne Raidal; Joe Pippia; Glenys Noble

Pharmacokinetics and Safety of Oral Doses of Meloxicam in Foals Less Than Six Weeks of Age

Sharanne Raidal, Joe Pippia, Glenys Noble

Agricultural, Environmental and Veterinary Sciences

Research output: Other contribution to conference › Abstract › peer-review

Abstract

Meloxicam is a potent non-steroidal anti-inflammatory drug (NSAID) that has been shown to be an effective analagesic and anti-inflammatory in adult horses at a dose rate of 0.6 mg/kg, PO, q 24 h. Pharmacokinetics and safety of this drug have not been reported in foals 6 wk of age.

Original language	English
Pages	33-33
Number of pages	1
Publication status	Published - 2009
Event	American Association of Equine Practitioners’ 55th Annual Convention - Mandalay Bay Convention Center, Las Vegas, United States Duration: 05 Dec 2009 → 09 Dec 2009

Conference

Conference	American Association of Equine Practitioners’ 55th Annual Convention
Country/Territory	United States
City	Las Vegas
Period	05/12/09 → 09/12/09

Cite this

@conference{8bf4eee2600c4952a4ab2b926915da9b,

title = "Pharmacokinetics and Safety of Oral Doses of Meloxicam in Foals Less Than Six Weeks of Age",

abstract = "Meloxicam is a potent non-steroidal anti-inflammatory drug (NSAID) that has been shown to be an effective analagesic and anti-inflammatory in adult horses at a dose rate of 0.6 mg/kg, PO, q 24 h. Pharmacokinetics and safety of this drug have not been reported in foals 6 wk of age.",

author = "Sharanne Raidal and Joe Pippia and Glenys Noble",

year = "2009",

language = "English",

pages = "33--33",

note = "American Association of Equine Practitioners{\textquoteright} 55th Annual Convention ; Conference date: 05-12-2009 Through 09-12-2009",

}

TY - CONF

T1 - Pharmacokinetics and Safety of Oral Doses of Meloxicam in Foals Less Than Six Weeks of Age

AU - Raidal, Sharanne

AU - Pippia, Joe

AU - Noble, Glenys

PY - 2009

Y1 - 2009

N2 - Meloxicam is a potent non-steroidal anti-inflammatory drug (NSAID) that has been shown to be an effective analagesic and anti-inflammatory in adult horses at a dose rate of 0.6 mg/kg, PO, q 24 h. Pharmacokinetics and safety of this drug have not been reported in foals 6 wk of age.

AB - Meloxicam is a potent non-steroidal anti-inflammatory drug (NSAID) that has been shown to be an effective analagesic and anti-inflammatory in adult horses at a dose rate of 0.6 mg/kg, PO, q 24 h. Pharmacokinetics and safety of this drug have not been reported in foals 6 wk of age.

M3 - Abstract

SP - 33

EP - 33

T2 - American Association of Equine Practitioners’ 55th Annual Convention

Y2 - 5 December 2009 through 9 December 2009

ER -

Pharmacokinetics and Safety of Oral Doses of Meloxicam in Foals Less Than Six Weeks of Age

Abstract

Conference

Fingerprint

Cite this